Based on the results of receiver operating characteristic (ROC) analysis, we demonstrated that the sensitivity and specificity for serum Fuc-Hpt levels for pancreatic cancer diagnosis were 85.1% and 82.3%, respectively (area under curve [AUC], 0.91). The gene discussed is MRS2; the disease is familial pancreatic carcinoma.